Truqap is often a kinase inhibitor that actually works by blocking pathways that aid the cancer cells survive and expand, so lowers cancer growth. Truqap is from a category of medicines called an AKT inhibitor. Truqap obtained FDA acceptance on November 17, 2023, soon after beneficial effects with the CAPItello-291 https://steveng544teo6.wikimidpoint.com/user